Sign in / Join Now
ETFs & Funds
Technology Partners (largest instit) exercised $8 (expiring) warnts bef $4.25 warnts to max sh cnt (ben ownership limit). Impresive.
Add a reply...
Latest StockTalks »
people get TNXP breaking news and analysis by email alert.
Get email alerts on TNXP »
Tonix Pharmaceuticals Holding Corp.
Get latest price
From other sites
Tonix Pharmaceuticals Presented Details Of Newly Expanded Product Development Pipeline At 9th Annual Biotech Showcase Conference
at TheStreet (Jan 10, 2017)
Tonix Pharmaceuticals To Present Breakthrough Therapy Designated-PTSD Program And Corporate Update At 9th Annual Biotech Showcase Conference
at TheStreet (Jan 3, 2017)
Tonix Pharmaceuticals' PTSD Phase 3-Ready Drug Candidate, TNX-102 SL, Granted Breakthrough Therapy Designation By The FDA
at TheStreet (Dec 19, 2016)
Tonix Pharmaceuticals Presented New Clinical Results From Sub-Group Analysis Of Phase 2 AtEase Study In Military-Related Posttraumatic Stress Disorder (PTSD)
at TheStreet (Dec 8, 2016)
Tonix Pharmaceuticals To Present Clinical Data At The 55th Annual Meeting Of The American College Of Neuropsychopharmacology (ACNP)
at TheStreet (Dec 2, 2016)